Security key
31189P102
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 122,159,363
- Share change
- -920,692
- Total reported value
- $400,671,566
- Put/Call ratio
- 93%
- Price per share
- $3.28
- Number of holders
- 176
- Value change
- -$37,762,295
- Number of buys
- 90
- Number of sells
- 70
Report period
Q2 2024
Institutions
176
Top holders
10
FATE full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
11%
|
13,169,057
|
$96,660,878 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
9,911,007
|
$72,746,792 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.4%
|
9,099,951
|
$66,793,642 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
6.7%
|
8,215,910
|
$60,304,779 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
6.6%
|
8,036,669
|
$58,989,150 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
4.6%
|
5,572,607
|
$40,902,935 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
4%
|
4,839,779
|
$35,523,978 | — | 31 Mar 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
2.8%
|
3,379,064
|
$24,802,330 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.6%
|
3,131,526
|
$22,985,401 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.5%
|
3,065,789
|
$22,502,891 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.2%
|
2,730,966
|
$20,045,290 | — | 31 Mar 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
2,562,852
|
$18,811,334 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.1%
|
2,548,304
|
$18,704,551 | — | 31 Mar 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
2.1%
|
2,527,747
|
$18,553,663 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.8%
|
2,190,408
|
$16,077,595 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.7%
|
2,140,000
|
$15,707,600 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
2,012,258
|
$14,769,973 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.6%
|
1,999,822
|
$14,678,693 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.6%
|
1,919,776
|
$14,091,156 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,905,983
|
$13,991,921 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
1,892,002
|
$13,887,295 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.5%
|
1,818,181
|
$13,345,449 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.4%
|
1,759,321
|
$12,913,416 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,714,124
|
$12,581,000 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.3%
|
1,584,300
|
$11,628,762 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.2%
|
1,437,700
|
$10,552,718 | — | 31 Mar 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.1%
|
1,355,352
|
$9,948,284 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.87%
|
1,063,179
|
$7,803,734 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.82%
|
1,007,378
|
$7,394,155 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.79%
|
965,431
|
$7,086,263 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.78%
|
956,331
|
$7,019,470 | — | 31 Mar 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.75%
|
920,476
|
$6,756,294 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.72%
|
886,925
|
$6,510,028 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.71%
|
870,000
|
$6,385,800 | — | 31 Mar 2024 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.65%
|
800,000
|
$5,872,000 | — | 31 Mar 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.6%
|
729,657
|
$5,355,682 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.59%
|
716,052
|
$5,255,822 | — | 31 Mar 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.57%
|
700,000
|
$5,138,000 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.51%
|
623,058
|
$4,573,246 | — | 31 Mar 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.43%
|
520,800
|
$3,822,672 | — | 31 Mar 2024 | |
| GCM Grosvenor Holdings, LLC |
13F
|
Company |
0.41%
|
495,916
|
$3,640,023 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.38%
|
460,000
|
$3,376,400 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
444,050
|
$3,259,327 | — | 31 Mar 2024 | |
| J. Scott Wolchko |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
871,248
mixed-class rows
|
$2,987,354 | — | 01 Feb 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.31%
|
383,201
|
$2,812,695 | — | 31 Mar 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
378,608
|
$2,778,983 | — | 31 Mar 2024 | |
| Artal Group S.A. |
13F
|
Company |
0.29%
|
360,311
|
$2,644,683 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.28%
|
345,437
|
$2,535,508 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.27%
|
324,243
|
$2,379,945 | — | 31 Mar 2024 | |
| Monaco Asset Management SAM |
13F
|
Company |
0.26%
|
316,805
|
$2,325,349 | — | 31 Mar 2024 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q2 2024
As of 30 Jun 2024,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
176 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
122,159,363 shares.
The largest 10 holders included
Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Inc., Boxer Capital, LLC, Deep Track Capital, LP, STATE STREET CORP, Bellevue Group AG, CITADEL ADVISORS LLC, D. E. Shaw & Co., Inc., and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This page lists
178
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
160
Q2 2024 holders
176
Holder diff
16
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.